HIV, HAART, and hyperlipidemia: balancing the effects.
Sherer
Renslow
R
Section of Infectious Diseases, Department of Medicine, University of Chicago Hospitals, Chicago, Illinois 60637, USA. rsherer@hektoen.org
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism / Q000821:virology; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000150:complications / Q000821:virology*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors